Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Clinical Trials (London, England)
|
February 18, 2018
Clinical trial quality: From supervision to collaboration and beyond
Ann Meeker-O'Connell, Coleen Glessner
Clinical Trials (London, England)
|
November 3, 2021
Can quality management drive evidence generation?
Ann Meeker-O'Connell, Ansalan Stewart, Coleen Glessner
Therapeutic Innovation & Regulatory Science
|
September 20, 2018
Quality by Design in Clinical Trials: A Collaborative Pilot With FDA
Kenneth Sprenger, David Nickerson, Ann Meeker-O'Connell, et al.
Therapeutic Innovation & Regulatory Science
|
May 20, 2025
Recent Updates to the Declaration of Helsinki: A View from the U.S. Food and Drug Administration
Robert M Califf, Ann Meeker-O'Connell, Shari Targum, et al.
Therapeutic Innovation & Regulatory Science
|
September 19, 2018
TransCelerate's Clinical Quality Management System: From a Vision to a Conceptual Framework
Ann Meeker-O'Connell, Leslie M Sam, Nanci Bergamo, et al.
JAMA Health Forum
|
May 2, 2025
Optimizing Informed Consent-A Call to Action
Nancy E Kass, Ann Meeker-O'Connell, Stephanie R Morain, et al.
Therapeutic Innovation & Regulatory Science
|
September 19, 2018
Enhancing Quality and Efficiency in Clinical Development Through a Clinical QMS Conceptual Framework: Concept Paper Vision and Outline
Ann Meeker-O'Connell, Maria Magdalena Borda, Janis A Little, et al.
Journal of Clinical and Translational Science
|
April 9, 2025
The importance of ClinicalTrials.gov in informing trial design, conduct, and results
Robert M Califf, Tracy L Cutler, Hilary D Marston, et al.
Clinical Trials (London, England)
|
April 22, 2016
Enhancing clinical evidence by proactively building quality into clinical trials
Ann Meeker-O'Connell, Coleen Glessner, Mark Behm, et al.
Clinical Trials (London, England)
|
December 4, 2013
Central site monitoring: results from a test of accuracy in identifying trials and sites failing Food and Drug Administration inspection
Anne S Lindblad, Zorayr Manukyan, Tejashri Purohit-Sheth, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Clinical Trials (London, England)
|
February 18, 2018
Clinical trial quality: From supervision to collaboration and beyond
Ann Meeker-O'Connell, Coleen Glessner
Clinical Trials (London, England)
|
November 3, 2021
Can quality management drive evidence generation?
Ann Meeker-O'Connell, Ansalan Stewart, Coleen Glessner
Therapeutic Innovation & Regulatory Science
|
September 20, 2018
Quality by Design in Clinical Trials: A Collaborative Pilot With FDA
Kenneth Sprenger, David Nickerson, Ann Meeker-O'Connell, et al.
Therapeutic Innovation & Regulatory Science
|
May 20, 2025
Recent Updates to the Declaration of Helsinki: A View from the U.S. Food and Drug Administration
Robert M Califf, Ann Meeker-O'Connell, Shari Targum, et al.
Therapeutic Innovation & Regulatory Science
|
September 19, 2018
TransCelerate's Clinical Quality Management System: From a Vision to a Conceptual Framework
Ann Meeker-O'Connell, Leslie M Sam, Nanci Bergamo, et al.
JAMA Health Forum
|
May 2, 2025
Optimizing Informed Consent-A Call to Action
Nancy E Kass, Ann Meeker-O'Connell, Stephanie R Morain, et al.
Therapeutic Innovation & Regulatory Science
|
September 19, 2018
Enhancing Quality and Efficiency in Clinical Development Through a Clinical QMS Conceptual Framework: Concept Paper Vision and Outline
Ann Meeker-O'Connell, Maria Magdalena Borda, Janis A Little, et al.
Journal of Clinical and Translational Science
|
April 9, 2025
The importance of ClinicalTrials.gov in informing trial design, conduct, and results
Robert M Califf, Tracy L Cutler, Hilary D Marston, et al.
Clinical Trials (London, England)
|
April 22, 2016
Enhancing clinical evidence by proactively building quality into clinical trials
Ann Meeker-O'Connell, Coleen Glessner, Mark Behm, et al.
Clinical Trials (London, England)
|
December 4, 2013
Central site monitoring: results from a test of accuracy in identifying trials and sites failing Food and Drug Administration inspection
Anne S Lindblad, Zorayr Manukyan, Tejashri Purohit-Sheth, et al.
Page
of 2